Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest National Institute of Health Stories

2013-09-18 23:24:45

Team to apply innovative analytical methods to gain new insights and identify potential therapies. New York (PRWEB) September 18, 2013 Scientists from the Icahn School of Medicine at Mount Sinai, in partnership with the New York Stem Cell Foundation (NYSCF), and other institutions, have been awarded a multi-year grant from the National Institutes of Health (NIH) to study Alzheimer’s disease. This study will apply innovative analytical methods to large-scale molecular, cellular, and...

2013-09-11 08:28:37

Genia's Single Molecule, Semiconductor Platform Will Significantly Drive Down the Cost of DNA Sequencing MOUNTAIN VIEW, Calif., Sept. 11, 2013 /PRNewswire/ -- Genia Technologies, Inc. today announced that the company, as part of a research consortium with Columbia University and Harvard Medical School, received a Revolutionary Genome Sequencing Technologies - The $1,000 Genome grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH)....

2013-09-10 23:20:15

NIH Consortium Seeks to Predict, Develop Prevention Strategies, and Understand Common Liver Injury Caused by Medications New York, NY (PRWEB) September 10, 2013 In an effort to better understand and develop prevention strategies for drug-induced liver injury (DILI), physician-scientists from the Icahn School of Medicine at Mount Sinai have joined the Drug-Induced Liver Injury Network (DILIN), a National Institutes of Health-funded consortium of only six academic medical centers in the...

2013-09-10 10:23:02

Scientists from NIH and Australia investigate risk factors that contribute to cerebral palsy and early infant death Karin B. Nelson, M.D., scientist emeritus at the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, and her colleagues from the University of Sydney, the University of Western Australia and Sydney Adventist Hospital in Australia examined the degree to which four specific risk factors contributed to cerebral palsy and...

2013-09-09 12:27:47

Novel Humanized Antibody Approach May Lead to Safer, More Cost Effective Treatment CLEVELAND, Sept. 9, 2013 /PRNewswire-USNewswire/ -- NovelMed Therapeutics (www.novelmed.com) announced the receipt of a combined $1.43 million SBIR Grant from the NIH. The first installment of the award (for $542,572) will be used to evaluate NovelMed's lead candidate's therapeutic superiority for treating Paroxysmal Nocturnal Hemoglobinuria (PNH). Subsequent funding, to be released on demonstration...

2013-09-09 08:56:31

National Institutes of Health (NIH) scientists report that a combination of two licensed antiviral drugs reduces virus replication and improves clinical outcome in a recently developed monkey model of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Their study, which appears as a letter in the Sept. 8 edition of Nature Medicine, expands on work published in April showing that a combination of ribavirin and interferon-alpha 2b stops MERS-CoV from replicating in cell culture....

2013-09-05 23:20:11

Colorectal Cancer Mortality is 49 Percent Higher Among African Americans New York, NY (PRWEB) September 05, 2013 Researchers at the Icahn School of Medicine at Mount Sinai have received a multi-year National Institutes of Health (NIH) grant to determine factors which may influence why African Americans are less likely than others to receive colorectal cancer (CRC) screenings, despite having the highest CRC incidence and mortality of any ethnic/racial group in America. “The short-term...

2013-09-04 08:32:43

CHARLOTTESVILLE, Va., Sept. 4, 2013 /PRNewswire/ -- Safe, new life-saving drug therapies may flow faster to patients who need them most, stimulated by a $1.6 million grant to HemoShear, LLC, from a division of the U.S. National Institutes of Health (NIH). HemoShear, LLC, is the pharmaceutical industry's leading developer of the most advanced human-relevant systems for applications in drug R&D. (Logo: http://photos.prnewswire.com/prnh/20120416/PH86899LOGO ) The grant...

2013-09-04 08:30:33

HeartIT wins $2.5M NIH grant to develop the "Cloud Based Corelab of the Future" DURHAM, N.C., Sept. 4, 2013 /PRNewswire/ -- HeartIT, the global leader that pioneered the first FDA approved zero-footprint medical imaging workstation, announced today that it has received a $2.5M grant from the NIH in order to develop the "Cloud Based Corelab of the Future." Medical drugs and devices are regulated by the U.S. Food and Drug Administration (FDA) based on data from multicenter clinical...

One Gene Adds To Mouse Longevity
2013-08-30 08:32:34

April Flowers for redOrbit.com - Your Universe Online Researchers led by the National Institutes of Health (NIH) have extended the average lifespan of a group of mice by lowering the expression of a single gene. The lifespan of the mice was increased by about 20 percent, or the equivalent of raising the average human life span by 16 years, from 79 to 95. The researchers focused on a gene called mTOR, which is involved in metabolism and energy balance, and might be connected with an...